Preventing saphenous vein graft failure: Does gene therapy have a role?

被引:17
作者
Akowuah, EF
Sheridan, PJ
Cooper, GJ
Newman, C
机构
[1] No Gen Hosp, Cardiovasc Res Grp, Dept Cardiothorac Surg, Sheffield S5 7AU, S Yorkshire, England
[2] Univ Sheffield, Cardiovasc Res Grp, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
10.1016/S0003-4975(03)00505-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy potentially allows local delivery and expression of cytokines, growth factors, and other mediators. In spite of increasing knowledge of the human genome, applications in clinical practice are only just beginning. The main limitations of effective clinical gene therapy are safety and low transfection efficiency. Saphenous vein grafts permit the transfection of the conduit ex vivo. This allows a variety of transfection techniques to be used, enhancing the transfection efficiency while limiting the risk of systemic complications. This review examines the potential mechanisms of gene delivery and genetic targets that may be applied to saphenous vein graft failure. (C) 2003 by The Society of Thoracic Surgeons.
引用
收藏
页码:959 / 966
页数:8
相关论文
共 68 条
[51]   ACTIVE OXYGEN SPECIES STIMULATE VASCULAR SMOOTH-MUSCLE CELL-GROWTH AND PROTOONCOGENE EXPRESSION [J].
RAO, GN ;
BERK, BC .
CIRCULATION RESEARCH, 1992, 70 (03) :593-599
[52]   Composite arterial Y graft has less coronary flow reserve than independent grafts [J].
Sakaguchi, G ;
Tadamura, E ;
Ohnaka, M ;
Tambara, K ;
Nishimura, K ;
Komeda, M .
ANNALS OF THORACIC SURGERY, 2002, 74 (02) :493-496
[53]   Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis [J].
Sata, M ;
Saiura, A ;
Kunisato, A ;
Tojo, A ;
Okada, S ;
Tokuhisa, T ;
Hirai, H ;
Makuuchi, M ;
Hirata, Y ;
Nagai, R .
NATURE MEDICINE, 2002, 8 (04) :403-409
[54]   THE ADVENT OF ADENOVIRUS - GENE-THERAPY FOR CARDIOVASCULAR-DISEASE [J].
SCHNEIDER, MD ;
FRENCH, BA .
CIRCULATION, 1993, 88 (04) :1937-1942
[55]   Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries - Potential for immunosuppression and vector engineering to overcome barriers of immunity [J].
Schulick, AH ;
Vassalli, G ;
Dunn, PF ;
Dong, G ;
Rade, JJ ;
Zamarron, C ;
Dichek, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :209-219
[56]   IN-VIVO GENE-TRANSFER INTO INJURED CAROTID ARTERIES - OPTIMIZATION AND EVALUATION OF ACUTE TOXICITY [J].
SCHULICK, AH ;
NEWMAN, KD ;
VIRMANI, R ;
DICHEK, DA .
CIRCULATION, 1995, 91 (09) :2407-2414
[57]   COMPARISON OF UPTAKE AND DEGRADATION OF LOW-DENSITY LIPOPROTEINS BY ARTERIES AND VEINS OF RABBITS [J].
SHAFI, S ;
PALINSKI, W ;
BORN, GVR .
ATHEROSCLEROSIS, 1987, 66 (1-2) :131-138
[58]   Adventitial remodeling after coronary arterial injury [J].
Shi, Y ;
Pieniek, M ;
Fard, A ;
OBrien, J ;
Mannion, JD ;
Zalewski, A .
CIRCULATION, 1996, 93 (02) :340-348
[59]  
SHITANI T, 2002, ANN THORAC SURG, V74, P1123
[60]   Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries [J].
Simari, RD ;
San, H ;
Rekhter, M ;
Ohno, T ;
Gordon, D ;
Nabel, GJ ;
Nabel, EG .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :225-235